Infectious Disease
Impact of the COVID-19 Pandemic on Chlamydia and Gonorrhea Screening in the U.S.
This study evaluates the impact of the COVID-19 pandemic on testing for common sexually transmitted infections. Specifically, changes are measured in chlamydia and gonorrhea testing and case detection among patients aged 14–49 years during the COVID-19 pandemic.Chlamydia and Gonorrhea: Shifting Age-Based Positivity Among Young Females, 2010–2017
This study aims to determine if and how the age distribution of Chlamydia trachomatis and Neisseria gonorrhoeae infections in women evolved from 2010 to 2017, given changes in sexual practices over this time.
